Latest News
AAVantgarde Bio, a clinical-stage biotechnology company advancing therapies for inherited retinal diseases (IRDs), has successfully closed a $141 million Series ...
We’re delighted to share that Pioneer portfolio company, Rinri Therapeutics, has secured regulatory approval from the MHRA to begin its ...
The highly anticipated finale of the 2025 Cranfield-Colworth Innovation Challenge on 19 March 2025 showcased cutting-edge solutions to pressing scientific ...
Alveron Pharma has announced the closing of a €5.0 million Series Seed extension financing to advance the development of its ...
A world-class impact accelerator will connect hundreds of East Midlands MedTech SMEs with health and care professionals, academics and the ...
Since launching our Golden Ticket Programme, Pioneer Group has partnered with a number of leading organisations, including Abbvie, CPI and ...
Pioneer Group has teamed up with global healthcare company Novo Nordisk to launch a Golden Ticket designed to help accelerate ...
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, todays announced ...
Recent research conducted by Pioneer Group sheds light on the life sciences investment trends shaping the current landscape, offering insights ...
